BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21865687)

  • 1. Immunomodulatory agents against IgA nephropathy.
    Tang SC; Leung JC; Lai KN
    Adv Otorhinolaryngol; 2011; 72():45-9. PubMed ID: 21865687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulating therapy for IgA nephropathy: rationale and evidence.
    Floege J; Eitner F
    Semin Nephrol; 2008 Jan; 28(1):38-47. PubMed ID: 18222345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A nephropathy in China: progress and challenges.
    Cai GY; Chen XM
    Am J Nephrol; 2009; 30(3):268-73. PubMed ID: 19521068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of IgA nephropathy: an update.
    Rosselli JL; Thacker SM; Karpinski JP; Petkewicz KA
    Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of IgA nephropathy.
    Barratt J; Feehally J
    Kidney Int; 2006 Jun; 69(11):1934-8. PubMed ID: 16641928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of progressive IgA nephropathy: an update.
    Wang W; Chen N
    Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM; Cabezas A; Calero F; Ballarín JA
    Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.
    Tamura S; Ueki K; Ideura H; Tsukada Y; Maezawa A; Kawai H; Wakamatsu R; Yano S; Nojima Y; Naruse T
    Clin Nephrol; 2001 Mar; 55(3):192-5. PubMed ID: 11316238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
    J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F; Vecchio LD; Pozzi C
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of IgA nephropathy].
    Matousovic K; Mestecky J; Tomana M; Novak J
    Vnitr Lek; 2008 Mar; 54(3):239-44. PubMed ID: 18522291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.